Related Experiment Video
Updated: Jan 30, 2026

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
10.0K
Utilizing a Faculty Development Program to Promote Safer Opioid Prescribing for Chronic Pain in Internal Medicine
Payel Roy1, Angela H Jackson1, Jeffrey Baxter2
1Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
Pain Medicine (Malden, Mass.)
|January 17, 2019
Summary
A skills-based faculty development program improved Internal Medicine faculty
Area of Science:
- Medical Education
- Clinical Practice
- Opioid Prescribing
Background:
- Internal Medicine faculty require enhanced skills in safe opioid prescribing.
- Effective resident teaching on opioid management is crucial for patient safety.
- Current faculty development programs may not adequately address clinical and teaching competencies in opioid stewardship.
Purpose of the Study:
- To implement and evaluate a skills-based faculty development program (FDP).
- To enhance Internal Medicine faculty's clinical skills in safe opioid prescribing.
- To improve faculty's ability to teach residents about safe opioid prescribing practices.
Main Methods:
- A faculty development program (FDP) incorporating a didactic session and Objective Structured Clinical Examination (OSCE).
- Focus on assessing opioid misuse risk, treatment outcomes, and aberrant behaviors.
- Pre- and post-program evaluation of faculty knowledge, attitudes, confidence, and self-reported resident teaching.
Main Results:
- Significant improvements observed in faculty knowledge (68% to 79%) and confidence (43.5% to 82.6% clinical; 45.8% to 83.3% teaching).
- Enhanced alignment of attitudes towards safer opioid prescribing post-FDP.
- Non-significant increases in self-reported resident teaching of safe opioid prescribing.
Conclusions:
- A skills-based FDP with didactic and OSCE components effectively improves faculty knowledge, attitudes, and confidence in safe opioid prescribing.
- Further training may be needed to enhance faculty's skills in teaching safe opioid prescribing to residents.
- This program serves as a model for improving opioid stewardship education within Internal Medicine.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.1K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.1K
Internal Receptors
74.6K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.6K
Opioid Receptors: Overview
4.3K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.3K
Internal Energy
36.7K
The total of all possible kinds of energy present in a substance is called the internal energy (U), sometimes symbolized as E. Suppose a system with initial internal energy, Uinitial, undergoes a change in energy (transfer of work or heat), and the final internal energy of the system is Ufinal. Change in internal energy equals the difference between Ufinal and Uinitial.
36.7K
The Eukaryotic Promoter Region
18.8K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.0K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.0K

